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Introduction: Dyspnea is a common presenting complaint for many patients in the emergency department.
Case Presentation: A 55-year-old man with type I diabetes presented to the emergency department with 
one month of intermittent palpitations and dyspnea. His lungs were clear to auscultation, and his chest 
radiograph was normal.  
Discussion: This case takes the reader through the differential diagnosis and systematic work-up of 
dyspnea with discussion of the diagnostic study, which ultimately led to this patient’s diagnosis and 
successful treatment. [Clin Pract Cases Emerg Med. 2020;4(2):111–115.]   
Keywords: Clinicopathological cases; cardiology; epidemiology.
CASE PRESENTATION (Dr. Eric R. Friedman):
A 55-year-old man presented to the emergency department 
(ED) of an urban, academic, medical center with intermittent 
palpitations (fast beats accompanied by a “pounding” sensation 
in the chest) for the prior month. Palpitations were most 
noticeable at night but had become more severe and constant 
over the preceding three days. He also reported shortness of 
breath while supine in bed and lightheadedness with exertion. 
The patient is an avid hiker, so he only presented once his 
dyspnea prevented him from completing a typical family hike. 
He denied any chest pain, fevers, weight loss, syncope, leg 
swelling, cough, nausea, vomiting, or rashes.
The patient was diagnosed with type 1 diabetes mellitus 
when he was 30 and has a history of hypertension. He was taking 
insulin glargine nightly with sliding-scale insulin aspart during 
meals and had recently switched from ramipril to losartan 50 
milligrams (mg) daily due to nocturnal cough. He denied any 
drug, alcohol, or tobacco use. His father died suddenly at age 42 
due to a heart attack. He denied any allergies. 
The patient’s vital signs on presentation were as follows: 
temperature 97.2 degrees Fahrenheit; blood pressure 131/83 
millimeters of mercury (mm Hg); pulse 55 beats per minute, 
respiratory rate 18 breaths per minute; and oxygen saturation 
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99% on room air, with a body mass index of 28.6 kilograms 
per meters squared. Physical exam revealed a well-developed 
and well-nourished male patient in no acute distress. His head 
was normocephalic and atraumatic. His eye exam was normal 
with pupils that were equal, round, and reactive to light. No 
scleral icterus was seen. His neck was supple and had normal 
range of motion. There was no jugular venous distension seen. 
The patient’s cardiac exam was notable for a bradycardic and 
irregularly irregular heartbeat without a murmur. His lungs 
were clear to auscultation bilaterally, and no wheezes or rales 
were heard. The patient’s abdomen was soft, non-tender, and 
non-distended. His extremities were warm and well perfused, 
and without edema. The patient’s cranial nerves II-XII were 
intact, and gait and strength assessments were unremarkable. 
No pronator drift was seen. Skin was normal in appearance, 
without any lesions or rashes. The patient demonstrated a 
normal mood and affect throughout the history and exam.
A chest radiograph (CXR) and electrocardiogram (ECG) 
were obtained (Images 1 and 2, respectively). Laboratory 
studies (Table) were notable for a white blood cell count of 6.2 
thousand per microliter, hemoglobin of 15.1 grams per deciliter, 
platelets of 190,000 per microliter, glucose 250 milligrams per 
deciliter, negative troponin, B-type natriuretic peptide (BNP) 
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of 502 picograms per deciliter, a thyroid stimulating hormone 
level of 1.2 milli-international units per liter with free thyroxine 
of 1.4 nanomoles per liter, and a Borrelia Burgdorferi IgM/IgG 
(immunoglobulin) titer of 0.28, negative antinuclear antibody 
test. (The latter test resulted after the patient was admitted.) 
While in the ED the patient experienced an acute episode of 
palpitations. His rhythm, as recorded by telemetry, is shown in 
Image 3. An echocardiograph was performed, which showed 
severe global hypokinesis with a left ventricular ejection 
fraction (LVEF) of 15%, mild dilation, biatrial enlargement, and 
no pericardial effusion. 
FACULTY DISCUSSION (Dr. J. David Gatz): 
I can feel my own heart racing as I work through this case. 
A passionate hiker myself, I immediately empathize with this 
patient’s concern of diminishing trail endurance. It is all quite 
alarming for a relatively young gentleman who otherwise 
seems healthy and active. He goes outdoors frequently and 
only has two chronic medical problems – insulin-dependent 
diabetes and hypertension. He did have a recent medication 
change, from ramipril to losartan, but this seems unlikely to 
be significant. It is alarming that his father suffered a cardiac-
related death at such a young age (only 42 years old!) and 
raises the question of a potential hereditary component to this 
presentation. His reported symptoms unfortunately don’t give 
us much additional direction: A month of palpitations with 
some exertional pre-syncope and orthopnea are rather vague. 
On exam, the patient’s vital signs are frustratingly benign. 
The respiratory rate of 18 breaths per minute is probably 
just an estimated number and not directly measured. He is 
slightly bradycardic at 55 beats per minute, which may be 
due to his baseline level of athletic activity. He is slightly 
hypertensive, but this is a known diagnosis. His physical exam 
appears normal except for an irregular rhythm on cardiac 
assessment. His labs are mostly benign. Mild hyperglycemia 
is reasonable in the setting of his diabetes. His Lyme titers are 
within normal ranges. The patient’s BNP, while not drastically 
elevated, is certainly higher than what we would expect in an 
otherwise healthy individual without an existing cardiac or 
renal diagnosis.
The patient’s ECG is abnormal and difficult to 
interpret. At first glance it appears to show a sinus 
bradycardia with first-degree atrioventricular (AV) block. 
There is left ventricular hypertrophy with repolarization 
abnormalities, and a left anterior fascicular block. Then, 
as if by premonition, the patient experiences a ventricular 
tachycardia. Understandably this triggers additional work-up 
including a CXR and an echocardiogram.
This is a large amount of information to work through, 
and it becomes essential to not miss the forest for the trees. 
Combining the patient’s initially vague symptoms with the 
left ventricular hypertrophy on his ECG, elevated BNP, and 
dilated hypokinetic echo, it is clear that this patient has a 
cardiomyopathy. The question becomes why? Something 
has made his cardiac tissue structurally and functionally 
abnormal, yet in the absence of any known coronary artery 
disease, valvular disease, or hypertension (currently just 
on monotherapy with only mildly elevated pressures in 
the ED). Cardiomyopathy is typically thought of as falling 
within one of three general categories: hypertrophic, dilated, 
or restrictive.1 The patient’s ECG does not demonstrate 
the classic findings we would expect in a septal or apical 
variant of hypertrophic cardiomyopathy.2 While there is an 
Image 1. Electrocardiogram of a 55-year-old male with palpitations 
and dyspnea, taken while in the emergency department.
Image 2. Anterior-posterior chest radiograph of a 55-year-old 
male with palpitations and dyspnea.
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AV block and widened QRS complexes, the patient’s ECG 
lacks the small voltages typically associated with a restrictive 
cardiomyopathy. Given that the patient’s echo demonstrates 
global hypokinesis (not apical) and there are no known 
significant new stressors in his life, his presentation does not 
seem consistent with a stress (Takotsubo) cardiomyopathy. 
Given all of this, it seems reasonable to narrow our search to 
potential causes of dilated cardiomyopathy (DCM).
But the number of etiologies just within DCM is long.3 
There are many known infectious causes (bacterial, viral, 
spirochetal, rickettsial, mycotic, protozoal, helminthic), but 
the patient has no fevers, antecedent illnesses, or laboratory 
evidence of infection. Lyme disease is an exciting thought 
given the patient’s outdoor activities, but the patient’s Lyme 
titers are within normal limits. While deposition diseases 
(hemochromatosis/amyloidosis) can cause DCM, there is no 
ECG evidence or associated stigmata. Numerous medications 
(especially chemotherapeutics and antiretrovirals) are known 
to cause DCM, but the patient is not taking any of them. 
Similarly, the patient has no history to suggest ingestion 
or exposure to toxins that could potentially cause DCM. 
Laboratory results and history exclude DCM secondary to 
any profound electrolyte, renal, or nutritional abnormalities. 
Diabetes can cause DCM, and while we don’t have a 
hemoglobin A1c to show whether his diabetes is controlled 
or not, it would be unlikely for a patient to present with DCM 
without a history of coronary artery disease, myocardial 
infarction, or any of the more common complications of 
diabetes (e.g., peripheral neuropathy, diabetic nephropathy, 
and retinopathy). There is no evidence of additional endocrine 
or genetic disorder. This leaves one final major category of 
potential etiologies – autoimmune processes. 
The autoimmune diseases that cause DCM include 
systemic lupus erythematosus (SLE), dermatomyositis, 
scleroderma, rheumatoid arthritis, and sarcoidosis. SLE is less 
likely because the patient doesn’t have the classic symptoms, 
the rash, or nephritis. Similarly, the classic cutaneous 
findings of dermatomyositis and scleroderma are not present. 
Sarcoidosis, however, can be much more subtle. With this in 
mind, the patient’s CXR seems to provide an essential clue.
Hilar structures on CXRs can be confusing. This 
patient’s CXR demonstrates additional “lumpy and bumpy” 
radiodensities in the hilar areas. In contrast to the smooth 
contours of bilateral pulmonary artery enlargement, these 
findings are consistent with hilar adenopathy, a finding 
suggestive of a neoplastic, infectious (tuberculosis, 
histoplasmosis), and inflammatory processes like sarcoidosis.4 
And thus, while this has been a long and winding path 
through the woods, we appear to have finally stumbled into a 
clearing. Sarcoidosis uniquely unifies our clinical suspicion 
of a DCM with the patient’s CXR. Moreover, the patient is 
the appropriate age and has experienced many of the typical 
symptoms including heart failure, AV blocks, and arrythmias. 
Lab test Value Units Normal range
White blood cell count 6.2 K/mcL 4.5 - 11.0
Hemoglobin 15.1 g/dL 12.6 - 17.4
Hematocrit 43.7 % 37.0 - 50.0
Mean corpuscular volume 85.7 fL 80.0 - 96.0
Mean corpuscular 
hemoglobin
29.6 pg 28.0 - 33.0
Mean corpuscular 
hemoglobin concentration
34.6 g/dL 33.0 - 36.0
Platelets 190 K/mcL 153 - 367
Mean platelet volume 11.6 fL 9.4 - 12.4
Red cell distribution width 13.3 % 12.0 - 15.2
Sodium 141 mmol/L 136 - 145
Potassium 4.5 mmol/L 3.5 - 5.1
Chloride 105 mmol/L 98 - 107
Bicarbonate 27 mmol/L 21 - 30
Glucose 250 mg/dL 70 - 99
Creatinine 1.01 mg/dL 0.66 - 1.25
Blood urea nitrogen 16 mg/dL 7-20
Calcium 9.2 mg/dL 8.6 - 10.2
Total protein 6.1 g/dL 6.3 - 8.2
Albumin 3.4 g/dL 3.5 - 5.2
Bilirubin total 0.9 mg/dL 0.3 - 1.2
Alkaline phosphatase 63 units/L 38 - 126
Aspartate 
aminotransferase
25 units/L 17 - 59
Alanine aminotransferase 40 units/L 21 - 72
Thyroid stimulating 
hormone
1.2 mIU/L 0.47 - 4.68
T4 free 1.4 ng/dL 0.6 - 2.5
Magnesium 1.8 mg/dL 1.6 - 2.6
Phosphorus 4.2 mg/dL 2.5 - 4.5
Borrelia burgdorferi IgG/
IgM Total*
0.28
Anti-nuclear antibody Neg
Brain natriuretic peptide 502 pg/mL <900
Troponin <0.02 ng/mL <0.07
*The amount of immunoglobulin G or M that are reactive to 
Borrelia antigen, results < 0.9 of the laboratory standard are 
considered negative. 
K, thousand; mcL, microliter; g, grams; dL, deciliter; fL, femtoliter; 
pg: picogram; mmol, millimoles; L, liter; mg, milligrams; mIU, milli-
international unit; ng, nanograms; pg, picograms; mL, milliliter; ng, 
nanograms; Ig: immunoglobulin; Neg, nagative.
Table. Laboratory results of a 55 year-old male with palpitations 
and dyspnea.
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Confirming the diagnosis can be attempted by cardiac biopsy, 
the classic diagnostic test, but this seems excessively invasive. 
Cardiac magnetic resonance imaging (MRI), however, has 
reasonable accuracy and is therefore my preferred diagnostic 
test. Hopefully a correct diagnosis and treatment will let this 
patient return to the trail for, as astutely noted by Hippocrates, 
“Walking is man’s best medicine.”
CASE OUTCOME (Dr. Friedman):
The patient was admitted to the cardiology service. 
Cardiac catherization was considered, but the patient 
instead received a cardiac MRI that showed DCM with 
extensive enhancement involving inferoseptal, inferior, and 
inferolateral segments from base to apex and mediastinal 
lymphadenopathy, with a severely decreased ventricular 
function and a LVEF of 21%. The patient had multiple runs 
of ventricular tachycardia while admitted and consequently 
received an automated implantable cardioverter-defibrillator 
(AICD). A hilar lymph node biopsy showed non-caseating 
granulomatous inflammation and multinucleated giant cells, 
consistent with sarcoidosis. The patient was originally 
started on prednisone 40 milligrams (mg) for the sarcoidosis 
and alprazolam 1 mg as needed due to post-traumatic 
stress disorder from his recurrent AICD shocks. He has 
since transitioned to 1 gram of mycophenolate mofetil 
and prednisone 35 mg daily. He is doing well and has not 
experienced any recent shocks from his AICD.  
RESIDENT DISCUSSION:
Sarcoidosis has a protean presentation, and the incidence 
of the disease varies widely among different cultural and 
racial groups: 1-2 persons per 100,000 of Japanese descent 
are affected, while 35-80 per 100,000 African-American 
persons are affected.5 Cardiac sarcoidosis is relatively rare, 
occurring in less than 5% of all cases.5 Untreated cardiac 
sarcoidosis can result in sudden cardiac death from ventricular 
tachyarrhythmias or atrioventricular blocks, and should be 
considered in patients with unexplained low LVEF, unexplained 
sustained ventricular tachycardia, and new AV block (usually 
Mobitz type II second degree or third degree).6 Endomyocardial 
biopsy has the highest specificity for the diagnosis of cardiac 
sarcoidosis but is rarely performed given the comparative 
ease and lack of complications associated with cardiac MRI.7 
Cardiac MRI has an acceptably high sensitivity and specificity 
of 89% and 78%, respectively.7 Cardiac MRI will usually show 
multiple areas of enhancement in a non-infarct pattern and will 
show direct enhancement from the left ventricle, across the 
interventricular segment, into the right ventricle.8  
Early treatment with immunosuppressants such as steroids 
can help treat cardiac sarcoidosis. In one case, a 32-year-old 
man with cardiac sarcoidosis had complete resolution of his 
AV block and ventricular tachycardia within two weeks of 
initiating steroid treatment. Follow-up cardiac MRI showed 
no further uptake, consistent with resolution of his cardiac 
sarcoidosis.9 This case illustrates a rare, deadly disease that 
was fortunately recognized early. The correct treatment was 
started, which resolved his symptoms and dysrhythmias.  
FINAL DIAGNOSIS:
Cardiac sarcoidosis.
KEY TEACHING POINTS:
1. Consider cardiac sarcoidosis in younger patients 
presenting with symptoms of heart failure, 
arrhythmias, or syncope.
2. Up to a quarter of cardiac sarcoidosis cases may occur 
in the absence of any extracardiac involvement.
3. The most typical radiographic features of thoracic 
sarcoidosis include symmetric hilar and mediastinal 
lymphadenopathy.
The authors attest that their institution requires neither Institutional 
Review Board approval, nor patient consent for publication of this 
case report. Documentation on file.
Image 3. Patient’s cardiac rhythm during an episode of palpitations that occurred while he was in the emergency department. ”HR 105” 
refers to the patient’s heart rate.
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